Older Drugs With Limited Trial Evidence: Are They Worth the Expense?

Ali Duarte-García; Eric Lawrence Matteson; Nilay D. Shah

doi:10.7326/L19-0520

Older Drugs With Limited Trial Evidence: Are They Worth the Expense?

Ali Duarte-García, Eric Lawrence Matteson, Nilay D. Shah

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Number of pages	1
Journal	Annals of internal medicine
Volume	171
Issue number	8
DOIs	https://doi.org/10.7326/L19-0520
State	Published - Oct 15 2019

ASJC Scopus subject areas

Internal Medicine

Access to Document

10.7326/L19-0520

Cite this

@article{9430fc353bb4439f9e5a93bf16c32c43,

title = "Older Drugs With Limited Trial Evidence: Are They Worth the Expense?",

author = "Ali Duarte-Garc{\'i}a and Matteson, {Eric Lawrence} and Shah, {Nilay D.}",

year = "2019",

month = oct,

day = "15",

doi = "10.7326/L19-0520",

language = "English (US)",

volume = "171",

journal = "Annals of Internal Medicine",

issn = "0003-4819",

publisher = "American College of Physicians",

number = "8",

}

TY - JOUR

T1 - Older Drugs With Limited Trial Evidence

T2 - Are They Worth the Expense?

AU - Duarte-García, Ali

AU - Matteson, Eric Lawrence

AU - Shah, Nilay D.

PY - 2019/10/15

Y1 - 2019/10/15

UR - http://www.scopus.com/inward/record.url?scp=85073179466&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85073179466&partnerID=8YFLogxK

U2 - 10.7326/L19-0520

DO - 10.7326/L19-0520

M3 - Article

C2 - 31610565

AN - SCOPUS:85073179466

SN - 0003-4819

VL - 171

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

IS - 8

ER -

Older Drugs With Limited Trial Evidence: Are They Worth the Expense?

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this